Cardiovascular involvement in Kawasaki disease

S Noel Narayanan1, M Zulfikar Ahamed, M Safia

  • 1Department of Pediatrics and Cardiology, SAT Hospital, Medical College, Thiruvananthapuram 695 011, India. noeln@asianetindia.com

Indian Pediatrics
|October 7, 2005
PubMed

Insights

Early treatment with IV gammaglobulin for Kawasaki disease prevents coronary artery issues. Prompt treatment in children with Kawasaki disease significantly reduces the risk of developing long-term cardiac complications like coronary artery disease.

Area of Science:

  • Pediatrics
  • Cardiology
  • Rheumatology

Background:

  • Kawasaki disease is a significant cause of acquired heart disease in children.
  • Cardiac involvement, including pancarditis and coronary artery abnormalities, is a major concern.

Purpose of the Study:

  • To evaluate cardiac involvement in children with Kawasaki disease.
  • To assess the long-term outcomes of coronary artery disease in affected children.
  • To determine the efficacy of intravenous immunoglobulin (IVIG) in preventing cardiac complications.

Main Methods:

  • Retrospective analysis of 72 patients diagnosed with Kawasaki disease over a 7-year period.
  • Cardiac assessment including echocardiography to detect pancarditis and coronary artery abnormalities.
  • Follow-up evaluation of coronary artery status and treatment outcomes.

Main Results:

  • 28% of patients experienced mild pancarditis, which resolved.
  • 18.5% developed coronary artery disease; 10 cases resolved within 1-2 years, while 3 had persistent dilatation/aneurysm.
  • Children receiving IV gammaglobulin within 10 days of illness onset showed no coronary artery disease during follow-up.

Conclusions:

  • Early administration of IV gammaglobulin is crucial for preventing coronary artery disease in Kawasaki disease.
  • Prompt treatment significantly reduces the incidence and severity of cardiac complications.
  • Long-term surveillance is important for children with persistent coronary artery abnormalities.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...